Long Term Support for Pediatric Cancer Adult Survivors in Rhône-Alpes : Evaluation of Women Fertility.

NCT02665819 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2018-02-20

No results posted yet for this study

Summary

PanCareLIFE Study is a cohort study of patients treated for cancer in childhood, and biological case-control study nested in the cohort (WP4) is coordinated by Erasmus MC-Sophia Children's Hospital in Holland.

Ensure optimal patient quality of life throughout his life is a priority for the research teams. PanCareLIFE Study also aims to identify the factors that predispose to impaired quality of life. It is in this light that will be offered to patients a quality of life questionnaires during the period of treatment and then periodically during long-term follow-up.

Conditions

  • Pediatric Cancer

Interventions

OTHER

Pediatric cancer women survivors

Women will incur a blood taking to obtain fertility indication.

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

    lead OTHER

Principal Investigators

  • BERGER Claire, MD · CHU SAINT-ETIENNE

  • Léonie CASAGRANDA, PhD · CHU SAINT-ETIENNE

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-23
Primary Completion
2016-11-29
Completion
2016-11-29

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02665819 on ClinicalTrials.gov